1.
Eandi M, Berno E, Pradelli L. Analisi costo/efficacia della doxofillina vs. teofillina nella terapia dell’asma cronica reversibile dell’adulto. FE [Internet]. 2002 Jun. 15 [cited 2025 Jul. 23];3(2):103-17. Available from: https://provafe.seedstm.com/index.php/FE/article/view/748